Spiration Inc. specializes in medical devices designed to improve lung function in patients suffering from severe emphysema and prolonged air leaks. The company's flagship product, the Spiration Valve, is a small, umbrella-shaped, one-way valve that is placed inside the airways of a lung. This device helps to redirect air from the less healthy to the more healthy parts of the lung, reducing overinflation and allowing trapped air and fluids to escape. This results in the healthier parts of the lung expanding and functioning more normally, thereby improving overall lung health.

Spiration operates in the medical device market, primarily serving healthcare providers and patients across Western and Eastern Europe, as well as the Americas. The company's business model revolves around the development, approval, and distribution of its proprietary valve system. Revenue is generated through the sale of these medical devices to hospitals and clinics, as well as through partnerships and licensing agreements.

The Spiration Valve has received FDA approval for the treatment of severe emphysema and has been FDA approved since 2008 for the management of prolonged air leaks. This regulatory approval underscores the device's efficacy and safety, making it a trusted solution for healthcare providers.

Keywords: medical device, lung function, severe emphysema, prolonged air leaks, Spiration Valve, FDA approved, healthcare providers, lung health, airways, overinflation.